PROBUPHINE Trademark

Trademark Overview

On Tuesday, March 5, 2013, a trademark application was filed for PROBUPHINE with the United States Patent and Trademark Office. The USPTO has given the PROBUPHINE trademark a serial number of 85867659. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 6, 2023. This trademark is owned by Titan Pharmaceuticals, Inc.. The PROBUPHINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and lifethreatening diseases
probuphine

General Information

Serial Number85867659
Word MarkPROBUPHINE
Filing DateTuesday, March 5, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 6, 2023
Registration Number5166633
Registration DateTuesday, March 21, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2013

Trademark Statements

Description of MarkThe mark consists of the word "PROBUPHINE", and the "I" in "PROBUPHINE" has four diagonal lines above it.
Goods and ServicesPharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and lifethreatening diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 6, 2023
Primary Code005
First Use Anywhere DateFriday, June 10, 2016
First Use In Commerce DateFriday, June 10, 2016

Trademark Owner History

Party NameTitan Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTitan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTitan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, January 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, January 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 6, 2023CANCELLED SEC. 8 (6-YR)
Monday, March 21, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 26, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 26, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 21, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, February 14, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, February 12, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 13, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 23, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 16, 2016TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, August 8, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 8, 2016NON-FINAL ACTION E-MAILED
Monday, August 8, 2016SU - NON-FINAL ACTION - WRITTEN
Sunday, August 7, 2016STATEMENT OF USE PROCESSING COMPLETE
Friday, July 22, 2016USE AMENDMENT FILED
Friday, July 22, 2016TEAS STATEMENT OF USE RECEIVED
Friday, February 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 4, 2016SOU EXTENSION 5 GRANTED
Wednesday, February 3, 2016SOU EXTENSION 5 FILED
Wednesday, February 3, 2016SOU TEAS EXTENSION RECEIVED
Thursday, August 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2015SOU EXTENSION 4 GRANTED
Tuesday, August 4, 2015SOU EXTENSION 4 FILED
Tuesday, August 4, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, January 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 24, 2015SOU EXTENSION 3 GRANTED
Thursday, January 22, 2015SOU EXTENSION 3 FILED
Thursday, January 22, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, August 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 23, 2014SOU EXTENSION 2 GRANTED
Friday, August 1, 2014SOU EXTENSION 2 FILED
Wednesday, August 20, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 1, 2014SOU TEAS EXTENSION RECEIVED
Saturday, February 15, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 13, 2014SOU EXTENSION 1 GRANTED
Thursday, February 13, 2014SOU EXTENSION 1 FILED
Thursday, February 13, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 9, 2013ASSIGNED TO LIE
Wednesday, May 1, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, May 1, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 1, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, May 1, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 30, 2013ASSIGNED TO EXAMINER
Tuesday, March 12, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 8, 2013NEW APPLICATION ENTERED

Related Keywords

probuphine system pharmaceuticals matrix sustained release treatment drugs based formulation implantable